See Stories from Region:
Filter by Date:
 
  • close  
  • close  
RSS – Biotechnology 
News > Science > Biotechnology

Featured

August 6, 2016 - 10:50 AM

PixarBio Corporation Announces Public Offering to Fund Development of NeuroRelease™, a Morphine Strength, Non-Opiate/Opioid, Non-Addictive Pain Treatment

Read More
August 5, 2016 - 07:58 PM

Lantern Pharma Announces Transaction to Evaluate BioNumerik’s Tavocept®

Lantern Pharma to evaluate BioNumerik’s Tavocept® for human therapeutic indications using Lantern’s…

Read More
August 5, 2016 - 04:30 PM

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and…

Read More

Latest

August 6, 2016 - 10:50 AM

PixarBio Corporation Announces Public Offering to Fund Development of NeuroRelease™, a Morphine Strength, Non-Opiate/Opioid, Non-Addictive Pain Treatment

Read More
August 5, 2016 - 07:58 PM

Lantern Pharma Announces Transaction to Evaluate BioNumerik’s Tavocept®

Lantern Pharma to evaluate BioNumerik’s Tavocept® for human therapeutic indications using Lantern’s 5-M theranostic platform.

Read More
August 5, 2016 - 04:30 PM

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression…

Read More
August 5, 2016 - 01:30 PM

Cytori Therapeutics Announced Inducement Grant for New Employee

Read More
August 5, 2016 - 12:19 PM

Cleobrothers & Company, Inc. and PGC Solutions, Ltd. Form Joint Venture to Distribute, Market and Promote Cleobrothers Medication Products in Nigeria

Cleobrothers & Co. announced that it signed a joint venture agreement with PGC Solutions, Ltd. to distribute, market and promote Cleobrothers branded…

Read More
August 5, 2016 - 06:01 AM

Aurinia Reports Second Quarter 2016 Financial Results and Operational Highlights

Completed private placement for gross proceeds of $7.08 million AURION results support the use of voclosporin for the treatment…

Read More